Clinical Trial Update: Study to Assess the Safety and Effectiveness of NMRA-335140-501 [Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase 3 study (NMRA-335140-501) evaluating safety and effectiveness in Major Depressive Disorder, which is currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• NMRA-335140-501 (NMRA-335140-501)

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 3 | Status: RECRUITING